Adverse Event Following Immunisation

A frontline health worker, Promila Devi, 55, died from severe complications she acquired after being vaccinated for Covid-19 in Himachal Pradesh’s Hamirpur district. This is the first such case of…

View Post

Latest News
Spotlight

National-Level Panel Discusses 8 AEFI Cases, Finds No Deaths Due To COVID-19 Vaccination: Health Ministry

February 9, 2021 18:53
Healthwire Bureau

WHO Study Shows Single-Dose HPV Vaccine Could Prevent Cervical Cancer Just as Effectively

The first meeting of the national-level AEFI (Adverse Event Following Immunisation) committee discussed eight AEFI cases and found that no deaths had occurred due to Covid-19 vaccination, according to the…

View Post

Latest News
Spotlight

Dry Run of COVID-19 Vaccination To Begin In Four States Today

December 28, 2020 09:25
Healthwire Bureau

A two-day dry run for the coronavirus vaccine program starts today in Andhra Pradesh, Punjab, Gujarat, and Assam. The aim of the exercise is to identify challenges and make required…

View Post

Menu

Adverse Event Following Immunisation

Himachal Pradesh: Anganwadi Worker Dies After Covid-19 Vaccination, Government Orders Probe

National-Level Panel Discusses 8 AEFI Cases, Finds No Deaths Due To COVID-19 Vaccination: Health Ministry

Dry Run of COVID-19 Vaccination To Begin In Four States Today

Vinod Kambli Admitted To Hospital In Maharshtra, Condition Critical

Diabetes and Inflammation Linked to Accelerated Brain Aging and Higher Dementia Risk: Experts

Heart Muscle Regeneration Observed in Patients with Artificial Hearts, Study Finds

Flesh-Eating Ulcer Cases Surge in Australia: Health Authorities Issue Warning

Epigamia Co-Founder Rohan Mirchandani Passes Away at 42 Due to Cardiac Arrest: Key Risk Factors and Warning Signs for Men in Their 40s

Does the 2022 H5N1 Virus Bind and Replicate Better in the Human Respiratory Tract? Here’s The Truth

Walking Speed Is An Indicator of Metabolic Health in Obese Individuals: Study Reveals

First-Ever Blood-Stage Malaria Vaccine Shows Promising Results in Phase IIb Trial